PURPOSE: Although inhaled corticosteroids are commonly used to treat patients with
chronic obstructive pulmonary disease (COPD), their effect on clinical outcomes such as …

Background: Clinical studies suggest that inhaled corticosteroids reduce exacerbations and
improve health status in chronic obstructive pulmonary disease (COPD). However, their …

Observational studies of inhaled corticosteroids in chronic obstructive pulmonary disease
(COPD) have shown improved survival whereas randomized trials have not. It has been …

Context Recent studies of inhaled corticosteroid (ICS) therapy for managing stable chronic
obstructive pulmonary disease (COPD) have yielded conflicting results regarding survival …

Recent data suggest that inhaled corticosteroids reduce the number of clinical
exacerbations in chronic obstructive pulmonary disease (COPD). It remains unknown …

BACKGROUND The role of inhaled corticosteroids in the long term management of chronic
obstructive pulmonary disease (COPD) is still unclear. A meta-analysis of the original data …

Background Recent studies have suggested a possible association between pneumonia
and the use of inhaled corticosteroids. We aimed to ascertain the risk of pneumonia with …

PURPOSE We wanted to review systematically the efficacy, effectiveness, and safety of
inhaled corticosteroids with respect to health outcomes in patients with chronic obstructive …

Background The role of inhaled corticosteroids (ICS) in chronic obstructive pulmonary
disease (COPD) has been the subject of much controversy. Major international guidelines …

Clinicians should consider the long-term risks of pneumonia with the use of inhaled
corticosteroids in patients with COPD. Adequately powered long-term head-to-head trials …